2021
DOI: 10.26420/austinjmedoncol.2021.1058
|View full text |Cite
|
Sign up to set email alerts
|

Radiotherapy after Breast-Preserving Surgery for Early Breast Cancer-Basic Principles and Our Experience

Abstract: Breast cancer is the second most common malignant tumor worldwide and the most common oncological disease among women. This article presents our experience in postoperative Radiotherapy (RT) in 341 patients with Early Breast Cancer (EBC) after Breast-Preserving Surgery (BPS). Emphasis is placed on the indications and Clinical Target Volumes (CTV) for radiotherapy. The significant effect of postoperative RT in terms of Local Tumor Control (LTC), long-term recurrence-free survival and overall survival is report… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…For stage IIA ВС, the decision was to treat her with chemotherapy followed by postmastectomy radiation therapy due to multiple risk factors, including focal lymphovascular space invasion and 2 positive lymph nodes [29]. Breast-preserving surgery with subsequent high-tech radiotherapy has a great contribution to achieving very good therapeutic and cosmetic results [30]. Adjuvant left breast radiotherapy (ALBRT) for breast cancer can result in a significant radiation dose to the heart [31].…”
Section: Discussionmentioning
confidence: 99%
“…For stage IIA ВС, the decision was to treat her with chemotherapy followed by postmastectomy radiation therapy due to multiple risk factors, including focal lymphovascular space invasion and 2 positive lymph nodes [29]. Breast-preserving surgery with subsequent high-tech radiotherapy has a great contribution to achieving very good therapeutic and cosmetic results [30]. Adjuvant left breast radiotherapy (ALBRT) for breast cancer can result in a significant radiation dose to the heart [31].…”
Section: Discussionmentioning
confidence: 99%